Stemson Therapeutics Appoints Matt Posard as Executive Chairman of the Board

Matt Posard, former senior executive at Illumina, has joined the Stemson Therapeutics team as Executive Chairman of the Board.  Matt brings over 30 years of executive experience in the life sciences industry.  He helped grow three companies – BioSite, GenProbe and Illumina – from early stage commercialization to major global success.  He is a seasoned board member and currently serves on multiple boards including Halozyme Therapeutics (NASDAQ: HALO), Dermtech, Talis BioMedical, Ingite Bio, and Fabric Genomics.

Matt will be intimately involved in the establishment of Stemson Therapeutics providing support to its co-founders, Geoff Hamilton and Dr. Alexey Terskikh, in executing product development, fund raising, building a great team, and business strategy.